Delivery Order SPE2DR25D2218-SPE2DR26FX4E4
- Not listed
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $2,652.23 to Amerisourcebergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract carries a firm fixed-price structure with an ultimate completion date of January 12, 2026, and was awarded on a competitive, non-set-aside basis. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,218.48 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, which is neither set-aside nor restricted to specific business categories, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. The award represents a task order issued under AmerisourceBergen's...
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $33,915.03 to Amerisourcebergen Drug Corp for the supply of Repatha 140 mg/ml SureClick autoinjectors. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 8, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under DLA's larger Indefinite Delivery Contract (IDC) with Cencora, Inc....
- On July 22, 2025, the Defense Logistics Agency awarded a delivery order contract valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by July 23, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- The Defense Logistics Agency awarded a $15,965.27 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on January 9, 2026, with completion targeted for January 12, 2026. This competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The contract carries no set-aside designation, reflecting full and open...
- The Defense Logistics Agency awarded a $13,410.70 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $4,103.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is a child order under AmerisourceBergen's parent company Cencora, Inc., carries an ultimate completion date of January 7, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded through open competition with...
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Repatha 140 mg/mL SureClick autoinjectors, valued at $20,864.65 with a firm fixed price structure. The contract is non-set-aside and competitively awarded, with an ultimate completion date of November 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DR25D2218Indefinite Delivery Contract
- SPE2DR25D2218-SPE2DR26FX4E4Delivery Order
On January 9, 2026, the Defense Logistics Agency awarded a $37,342.01 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with performance through January 12, 2026. The contract utilizes firm fixed-price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. (doing business as AmerisourceBergen) providing overall organizational oversight. The work will be performed at the Conshohocken facility. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The Repatha delivery supports federal medical procurement for military and veteran healthcare systems, ensuring access to this cardiovascular medication for eligible beneficiaries within the Defense Health Agency and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.3k | 1/8/26 |